glp-1 obesity drug news today oct 23 2025 CVS deal puts Lilly on equal footing with Novo GLP-1 Agonists: Using Semaglutide, Tirzepatide,

Data from 81 selected studies were extracted and analyzed, focusing on mental health outcomes and reported adverse effects

Discover effective Weightmanagement with Weightless Patches, infused with natural ingredients like berberine and pomegranate to boost metabolism and curb cravings naturally.

Background Glucagon-like peptide-1 (GLP-1) induces diuresis and natriuresis

Greger cuts through the promotional puffery and presents the pros and cons of these weight-loss drugs so individuals can make up their own mind in the face of the very real and devastating consequences of obesity

Results Despite heterogeneity in study designs and populations, a largely consistent association was found between GLP-1RA use and a reduced incidence of glaucoma